Latest News about BNTX
Recent news which mentions BNTX
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
September 06, 2024
From Benzinga
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
September 03, 2024
From Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
From Benzinga
Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
August 26, 2024
From Benzinga
FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
August 22, 2024
From Benzinga
From Benzinga
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
August 19, 2024
From Benzinga
From Motley Fool
Why Pfizer Stock Slumped on Friday
August 16, 2024
From Motley Fool
Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
August 16, 2024
From Benzinga
From Benzinga
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
From Benzinga
3 Biotech Stocks With Promising Drug Pipelines: August 2024
August 08, 2024
From InvestorPlace
This Cognizant Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
August 07, 2024
From Benzinga
US Stocks Trim Black Monday's Drops As Services Gauge Expands, Bond Gains Stall As Traders Reassess Fed Cuts: What's Driving Markets Monday?
August 05, 2024
From Benzinga
Tickers
BNTX
From InvestorPlace
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
August 05, 2024
From Benzinga
Nasdaq, R2K Futures Tumble Over 4%, VIX Spikes Over 100%, Bitcoin Plunges Hard As Global Sell-Off Deepens Amid Recession Fears
August 05, 2024
From Benzinga
What's Going On With BioNTech (BNTX) Shares?
August 01, 2024
From Benzinga
From Benzinga
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
From Benzinga
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
July 02, 2024
From Benzinga
3 Nasdaq Stocks to Sell in July Before They Crash & Burn
July 02, 2024
From InvestorPlace
From InvestorPlace
From InvestorPlace
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.